Skip to content

Search Results

997 Results

Choosing Wisely

On April 23, 2015 APA published a revision to the third item on its Choosing Wisely list to better reflect that there are instances in which dementia-associated symptoms (e.g., aggressive behavior due to paranoid delusions) pose an acute threat to the individual and others, and in these instances antipsychotic medications must be used before formal nonpharmacologic measures can be instituted.

FDA Approves Novel Depression Treatment

  • Depression, Patients and Families

Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes

Lifestyle Factors Key to Reducing Risk for Dementia, Late Life Depression

  • Depression, Healthy living for mental well-being, Older adults, Patients and Families

A recent study highlights the lifestyle factors that can be protective against age-related brain conditions, including depression and late life depression. The research used the “Brain Care Score,” measuring lifestyle factors, and found that a higher Brain Care Score is associated with a lower risk of age-related brain disease, including stroke, late-life depression, and dementia.

Structural Racism Task Force

The APA Presidential Task Force to Address Structural Racism Throughout Psychiatry was formed by APA President Dr. Jeffrey Geller in June 2020.

Covid-19 / Coronavirus

To provide support in the response to the novel coronavirus (COVID-19), APA is collecting credible and useful resources in this information hub.

Cannabis

Learn about various aspects of treating cannabis use disorders, including clinical, training, and policy considerations. As new topics emerge, more resources and information will be added to this page. The resources covers topics from the APA Work Group on Cannabis with the Council on Addiction Psychiatry, training, practice/clinical, and legal issues from leading psychiatrists.

Interoperability and Information Blocking

When Congress passed the 21st Century Cures Act in 2016, it included in it Section 4004, which specifies certain practices that could constitute information blocking. In May 2020, the ONC released its Final Rule for 21st Century Cures. An overview of the Rule, its complete text, and various Fact Sheets can be accessed here.

Medical leadership for mind, brain and body.

Join Today